rxstat › Shortages › Hydrochlorothiazide Losartan

Hydrochlorothiazide Losartan (Hyzaar, Hyzaar Ds) shortage status

Shortage anticipated

Source: Health Canada shortage reports · Updated Oct 6, 2026

A shortage of Hydrochlorothiazide Losartan is anticipated but not yet confirmed. 1 product(s) have anticipated-shortage reports on file with Health Canada.

A combination of a blood pressure medication and a water pill used to treat high blood pressure.

Products affected
0 / 35
Reports on file
170

Shortage history

2023 2024 2025 2026

Shortage history (red bands = periods in shortage).

Reports by product

The DIN is printed on your prescription label.

Anticipated
PMS-LOSARTAN-HCTZ
12.5MG 50MG · TABLET · PHARMASCIENCE INC
DIN 02392224 · Disruption of the manufacture of the drug.
Resolved
SANDOZ LOSARTAN HCT
100MG 12.5MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02362449 · ended Sep 8, 2026 · Disruption of the manufacture of the drug.
Resolved
LOSARTAN HCT
12.5MG 50MG · TABLET · SIVEM PHARMACEUTICALS ULC
DIN 02388960 · ended Oct 7, 2025 · Requirements related to complying with good manufacturing practices.
Resolved
LOSARTAN HCT
12.5MG 50MG · TABLET · SIVEM PHARMACEUTICALS ULC
DIN 02388960 · ended Oct 7, 2025 · Requirements related to complying with good manufacturing practices.
Resolved
LOSARTAN HCT
12.5MG 100MG · TABLET · SIVEM PHARMACEUTICALS ULC
DIN 02388979 · ended Oct 7, 2025 · Requirements related to complying with good manufacturing practices.
Resolved
LOSARTAN HCT
12.5MG 100MG · TABLET · SIVEM PHARMACEUTICALS ULC
DIN 02388979 · ended Oct 7, 2025 · Requirements related to complying with good manufacturing practices.
Resolved
HYZAAR DS
25MG 100MG · TABLET · ORGANON CANADA INC.
DIN 02241007 · ended Aug 21, 2026 · Delay in shipping of the drug.
Resolved
PMS-LOSARTAN-HCTZ
12.5MG 100MG · TABLET · PHARMASCIENCE INC
DIN 02392232 · ended Jul 27, 2026 · Disruption of the manufacture of the drug.
Resolved
SANDOZ LOSARTAN HCT
12.5MG 100MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02362449 · ended Jun 29, 2026 · Demand increase for the drug.
Resolved
SANDOZ LOSARTAN HCT
50MG 12.5MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02313375 · ended Jun 22, 2026 · Demand increase for the drug.
Resolved
PMS-LOSARTAN-HCTZ
12.5MG 50MG · TABLET · PHARMASCIENCE INC
DIN 02392224 · ended May 4, 2026 · Disruption of the manufacture of the drug.
Resolved
LOSARTAN HCT DS
25MG 100MG · TABLET · SIVEM PHARMACEUTICALS ULC
DIN 02388987 · ended Oct 21, 2025 · Requirements related to complying with good manufacturing practices.

Showing 12 of 60 reports. All reports are on file with Health Canada.

What's happening

A manufacturer has told Health Canada it expects supply of Hydrochlorothiazide Losartan to fall short of demand. Anticipated shortages sometimes resolve without patients noticing; this page updates as soon as the status changes.

Hydrochlorothiazide Losartan is classified under “ANGIOTENSIN II ANTAGONISTS, COMBINATIONS” (ATC C09DA).

Recent changes

Common questions

What is Hydrochlorothiazide Losartan used for?

A combination of a blood pressure medication and a water pill used to treat high blood pressure.

When will Hydrochlorothiazide Losartan be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is Hydrochlorothiazide Losartan in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Possible alternatives in the same class (angiotensin ii antagonists, combinations)

Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.